首页LAURUSLABS • NSE
Laurus Labs Ltd
₹533.00
1月27日, GMT+5:30 15:59:08 · INR · NSE · 免责声明
股票在IN上市的证券
昨日收盘价
₹602.65
当日价格范围
₹501.15 - ₹610.00
年度波幅
₹360.85 - ₹619.40
市值
2892.26亿 INR
平均交易量
183.90万
市盈率
143.55
股息率
0.15%
主要交易所
NSE
相关资讯
财务信息
损益表
收入
净收入
(INR)2024年12月年同比变化
收入
142.45亿19.21%
经营支出
62.58亿10.95%
净收入
9.23亿298.88%
净利润率
6.48234.02%
每股收益
1.71297.67%
息税折旧摊销前利润
28.05亿71.81%
有效税率
30.13%
总资产
负债总额
(INR)2024年12月年同比变化
现金及短期投资
总资产
负债总额
权益总额
发行在外的股份
5.40亿
市净率
资产回报率
资本回报率
6.80%
现金净变动
(INR)2024年12月年同比变化
净收入
9.23亿298.88%
来自运营的现金
投资现金
融资现金
现金净变动
自由现金流
简介
Laurus Labs is an Indian multinational pharmaceutical and biotechnology company headquartered in Hyderabad. Its focus areas include active pharmaceutical ingredients, generic formulations, custom synthesis, biotechnology, veterinary APIs and agrochemicals. The company was founded in 2005 by Satyanarayana Chava. Laurus Labs has its eight manufacturing plants located at Visakhapatnam, Hyderabad and Bangalore. The manufacturing units have received one or more approvals from USFDA, WHO, NIP Hungary, KFDA, MHRA, TGA, and PMDA. The company operates through its subsidiaries in Europe and United States and also offers its services in contract research, clinical research and analytical research through its R&D centers. The R&D centres are based in Hyderabad, Visakhapatnam and United States. Wikipedia
成立时间
2005
员工数量
6,007
搜索
清除搜索内容
关闭搜索框
Google 应用
主菜单